Paper18636588
Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production.
Zhou W and 3 others. Biotechnol Bioeng, 1997. Cited by 87 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. Papers, record 18636588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18636588
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,513,814 | Time-Resolved Monitoring of the Oxygen Transfer Rate of Chinese Hamster Ovary Cells Provides Insights Into Culture Behavior in Shake Flasks. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34513814 | PubMed |
| 29,382,079 | A Simple Method to Reduce both Lactic Acid and Ammonium Production in Industrial Animal Cell Culture. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29382079 | PubMed |
| 29,322,349 | Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content. | Cytotechnology | 2018 | https://conductscience.org/library/papers/29322349 | PubMed |
| 25,723,523 | Cyclin and DNA distributed cell cycle model for GS-NS0 cells. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/25723523 | PubMed |
| 24,939,591 | Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains. | Cytotechnology | 2015 | https://conductscience.org/library/papers/24939591 | PubMed |
| 24,688,682 | Bioprocess systems engineering: transferring traditional process engineering principles to industrial biotechnology. | Comput Struct Biotechnol J | 2012 | https://conductscience.org/library/papers/24688682 | PubMed |
| 23,908,655 | Expression of recombinant antibodies. | Front Immunol | 2013 | https://conductscience.org/library/papers/23908655 | PubMed |
| 23,436,783 | Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation. | Biotechnol Prog | 2013 | https://conductscience.org/library/papers/23436783 | PubMed |
| 22,358,934 | Large scale production of recombinant mouse and rat growth hormone by fed-batch GS-NSO cell cultures. | Cytotechnology | 1996 | https://conductscience.org/library/papers/22358934 | PubMed |
| 22,033,470 | Glycosylation and post-translational modification gene expression analysis by DNA microarrays for cultured mammalian cells. | Methods | 2012 | https://conductscience.org/library/papers/22033470 | PubMed |
| 20,967,331 | High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. | Analyst | 2011 | https://conductscience.org/library/papers/20967331 | PubMed |
| 20,659,585 | Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20659585 | PubMed |
| 19,003,032 | Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture. | Cytotechnology | 2005 | https://conductscience.org/library/papers/19003032 | PubMed |
| 19,002,973 | Advances in animal cell recombinant protein production: GS-NS0 expression system. | Cytotechnology | 2000 | https://conductscience.org/library/papers/19002973 | PubMed |
| 19,002,906 | Amino acids metabolism by VO 208 hybridoma cells: some aspects of the culture process and medium composition influence. | Cytotechnology | 2001 | https://conductscience.org/library/papers/19002906 | PubMed |
| 19,002,863 | Fed-batch culture optimization of a growth-associated hybridoma cell line in chemically defined protein-free media. | Cytotechnology | 2006 | https://conductscience.org/library/papers/19002863 | PubMed |
| 17,263,345 | Characterization and resolution of evaporation-mediated osmolality shifts that constrain microfluidic cell culture in poly(dimethylsiloxane) devices. | Anal Chem | 2007 | https://conductscience.org/library/papers/17263345 | PubMed |
| 17,172,663 | Development of transfection and high-producer screening protocols for the CHOK1SV cell system. | Mol Biotechnol | 2006 | https://conductscience.org/library/papers/17172663 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18636588
GET https://conductscience.org/api/papers/v1/18636588/authors